Literature DB >> 11840429

Treating rheumatoid arthritis early: a window of opportunity?

James R O'Dell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11840429     DOI： 10.1002/art.10092

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  46 in total

1.  Organising pneumonia as the first manifestation of rheumatoid arthritis.

Authors:  Chisho Hoshino; Noriyuki Satoh; Masashi Narita; Akio Kikuchi; Minoru Inoue
Journal:  BMJ Case Rep       Date:  2011-03-24

Review 2.  [Early diagnosis of rheumatoid arthritis].

Authors:  M Schneider; B Ostendorf; C H Specker
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

3.  Optimal use of methotrexate: the advantages of tight control.

Authors:  J W J Bijlsma; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

4.  Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF.

Authors:  I G Silveira; R W Burlingame; C A von Mühlen; A L Bender; H L Staub
Journal:  Clin Rheumatol       Date:  2007-04-05       Impact factor: 2.980

5.  Activin A: a potential therapeutic target for characterizing and stopping joint pain early in rheumatoid arthritis patients.

Authors:  Fei Dong; Xijing He
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

6.  Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Victor Grijalva; Sogol Amjadi; John FitzGerald; Veena K Ranganath; Mihaela Taylor; Maureen McMahon; Harold E Paulus; Srinivasa T Reddy
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

Review 7.  Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications.

Authors:  Francisco Espinoza; Sylvie Fabre; Yves-Marie Pers
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-06-13       Impact factor: 5.346

8.  High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study.

Authors:  Hilal Maradit Kremers; Cynthia S Crowson; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2008-08

9.  Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.

Authors:  Marion A J van Rossum; Renée M van Soesbergen; Maarten Boers; Aeilko H Zwinderman; Theo J W Fiselier; Marcel J A M Franssen; Rebecca ten Cate; Lisette W A van Suijlekom-Smit; Nico M Wulffraat; Wilma H J van Luijk; Johanna C M Oostveen; Wietse Kuis; Ben A C Dijkmans
Journal:  Ann Rheum Dis       Date:  2007-05-09       Impact factor: 19.103

10.  Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.

Authors:  Eriko Kudo-Tanaka; Shiro Ohshima; Masaru Ishii; Toru Mima; Masato Matsushita; Naoto Azuma; Yoshinori Harada; Yoshinori Katada; Hitomi Ikeue; Mitsuko Umeshita-Sasai; Kunio Miyatake; Yukihiko Saeki
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.